MENU
PTN
AS OF
Jan 14 closing price
Price
$16.81
Change
-$0.39 (-2.27%)
Capitalization
28.62M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PTN
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Palatin Technologies (PTN) Ownership - Who owns Palatin Technologies?

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
4B Cedar Brook Drive
Phone
+1 609 495-2200
Employees
34
Web
https://www.palatin.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.62M
P/E Ratio
N/A
Total Cash
324.14K
Projected Growth
N/A
Total Debt
132.45K
Revenue
8.85M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
0.02
Revenue/Share
12.40 USD as % of share price

Fundamentals

PTN
Capitalization
28.6M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
324K
Total Cash/Share
0.19
Total Debt
132K
Total Debt/Equity
0.02
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
12.40%
Revenue
8.85M
ROE
N/A
Book Value
396K
P/B Ratio
72.46
Cash Flow
N/A
Earnings
-7.63
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9.73K
Current Ratio
1.02
Current Revenue Per Employee
305087.94
Dividends Per Share - Security
N/A
EBITDA
-4.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-79.90
Shares Held By Institutions
N/A
Shares Outstanding - Current
1.7M
Total Liabilities
8.22M
Total Volume MTD
N/A
Value
-1
Gain YTD
11.834
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PTN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for PTN
A.I. Advisor
published General Information

General Information

a developer of peptide, peptide mimetic and small molecule agonist compounds

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4B Cedar Brook Drive
Phone
+1 609 495-2200
Employees
34
Web
https://www.palatin.com